BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 38719587)

  • 1. Efficient production of human interleukin-3 from Escherichia coli using protein disulfide isomerase b'a' domain.
    Nguyen TKO; Ryu D; Nguyen MQ; Ta HKK; Vu TL; Choe H
    Biotechnol J; 2024 May; 19(5):e2300581. PubMed ID: 38719587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prokaryotic soluble overexpression and purification of bioactive human growth hormone by fusion to thioredoxin, maltose binding protein, and protein disulfide isomerase.
    Nguyen MT; Koo BK; Thi Vu TT; Song JA; Chong SH; Jeong B; Ryu HB; Moh SH; Choe H
    PLoS One; 2014; 9(3):e89038. PubMed ID: 24614134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble prokaryotic overexpression and purification of bioactive human granulocyte colony-stimulating factor by maltose binding protein and protein disulfide isomerase.
    Do BH; Ryu HB; Hoang P; Koo BK; Choe H
    PLoS One; 2014; 9(3):e89906. PubMed ID: 24594699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Prokaryotic Overexpression and Purification of Human GM-CSF Using the Protein Disulfide Isomerase b'a' Domain.
    Nguyen TKO; Vu TL; Nguyen MQ; Ta HKK; Park KS; Kim SH; Kim CJ; Jang YJ; Choe H
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34067755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Soluble expression of human leukemia inhibitory factor with protein disulfide isomerase in Escherichia coli and its simple purification.
    Song JA; Koo BK; Chong SH; Kim K; Choi DK; Thi Vu TT; Nguyen MT; Jeong B; Ryu HB; Kim I; Jang YJ; Robinson RC; Choe H
    PLoS One; 2013; 8(12):e83781. PubMed ID: 24358310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prokaryotic Soluble Overexpression and Purification of Human VEGF165 by Fusion to a Maltose Binding Protein Tag.
    Nguyen MT; Krupa M; Koo BK; Song JA; Vu TT; Do BH; Nguyen AN; Seo T; Yoo J; Jeong B; Jin J; Lee KJ; Oh HB; Choe H
    PLoS One; 2016; 11(5):e0156296. PubMed ID: 27231876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prokaryotic soluble expression and purification of bioactive human fibroblast growth factor 21 using maltose-binding protein.
    Nguyen AN; Song JA; Nguyen MT; Do BH; Kwon GG; Park SS; Yoo J; Jang J; Jin J; Osborn MJ; Jang YJ; Thi Vu TT; Oh HB; Choe H
    Sci Rep; 2017 Nov; 7(1):16139. PubMed ID: 29170489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bacterial overexpression and purification of soluble recombinant human serum albumin using maltose-binding protein and protein disulphide isomerase.
    Nguyen MT; Heo Y; Do BH; Baek S; Kim CJ; Jang YJ; Lee W; Choe H
    Protein Expr Purif; 2020 Mar; 167():105530. PubMed ID: 31698036
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prokaryotic soluble overexpression and purification of oncostatin M using a fusion approach and genetically engineered E. coli strains.
    Nguyen MT; Prima MJ; Song JA; Kim J; Do BH; Yoo J; Park S; Jang J; Lee S; Lee E; Novais MP; Seo HB; Lee SY; Cho ML; Kim CJ; Jang YJ; Choe H
    Sci Rep; 2019 Sep; 9(1):13706. PubMed ID: 31548569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel Bacterial Production of Two Different Bioactive Forms of Human Stem-Cell Factor.
    Lee E; de Paula MN; Baek S; Ta HKK; Nguyen MT; Jeong TH; Kim CJ; Jang YJ; Choe H
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34198626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble Prokaryotic Expression and Purification of Bioactive Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand.
    Do BH; Nguyen MT; Song JA; Park S; Yoo J; Jang J; Lee S; So S; Yoon Y; Kim I; Lee K; Jang YJ; Choe H
    J Microbiol Biotechnol; 2017 Dec; 27(12):2156-2164. PubMed ID: 29032646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble prokaryotic expression and purification of crotamine using an N-terminal maltose-binding protein tag.
    Vu TT; Jeong B; Yu J; Koo BK; Jo SH; Robinson RC; Choe H
    Toxicon; 2014 Dec; 92():157-65. PubMed ID: 25448388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cu/Zn incorporation during purification of soluble human EC-SOD from E. coli stabilizes proper disulfide bond formation.
    Bae JY; Koo BK; Ryu HB; Song JA; Nguyen MT; Vu TT; Son YJ; Lee HK; Choe H
    Appl Biochem Biotechnol; 2013 Mar; 169(5):1633-47. PubMed ID: 23329142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Prokaryotic Expression and Purification of Human Interferon Alpha-2b Using a Maltose-Binding Protein Tag.
    Vu TT; Jeong B; Krupa M; Kwon U; Song JA; Do BH; Nguyen MT; Seo T; Nguyen AN; Joo CH; Choe H
    J Mol Microbiol Biotechnol; 2016; 26(6):359-368. PubMed ID: 27463335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble overexpression and purification of bioactive human CCL2 in E. coli by maltose-binding protein.
    Vu TT; Koo BK; Song JA; Chong SH; Park CR; Nguyen MT; Jeong B; Ryu HB; Seong JY; Jang YJ; Robinson RC; Choe H
    Mol Biol Rep; 2015 Mar; 42(3):651-63. PubMed ID: 25391768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of Functional Human Sialyltransferases ST3Gal1 and ST6Gal1 in Escherichia coli.
    Ortiz-Soto ME; Seibel J
    PLoS One; 2016; 11(5):e0155410. PubMed ID: 27166796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison between MBP- and NT* as N-terminal fusion partner for recombinant protein production in E. coli.
    Raran-Kurussi S; Sharwanlal SB; Balasubramanian D; Mote KR
    Protein Expr Purif; 2022 Jan; 189():105991. PubMed ID: 34628000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The ability to enhance the solubility of its fusion partners is an intrinsic property of maltose-binding protein but their folding is either spontaneous or chaperone-mediated.
    Raran-Kurussi S; Waugh DS
    PLoS One; 2012; 7(11):e49589. PubMed ID: 23166722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and Purification of Recombinant Proteins in Escherichia coli with a His
    Raran-Kurussi S; Waugh DS
    Methods Mol Biol; 2017; 1607():1-15. PubMed ID: 28573567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and purification of the recombinant diphtheria fusion toxin DT388IL3 for phase I clinical trials.
    Urieto JO; Liu T; Black JH; Cohen KA; Hall PD; Willingham MC; Pennell LK; Hogge DE; Kreitman RJ; Frankel AE
    Protein Expr Purif; 2004 Jan; 33(1):123-33. PubMed ID: 14680969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.